mPulse Appoints Nanda as CTO and Kowalow as CBOO to Scale HXI
- Harish Nanda appointed as Chief Technology Officer
- Erin Kowalow named Chief Business Operations Officer
- mPulse focuses on scaling Health Experience and Insights (HXI)
- Appointments announced Tuesday, 6 October 2026
- Company aims to improve patient outcomes through data-driven engagement
mPulse, the prominent leader in Health Experience and Insights (HXI), confirmed on Tuesday, 6 October 2026, that it has appointed 2 new executive leaders: Harish Nanda as its new Chief Technology Officer and Erin Kowalow as its Chief Business Operations Officer. The dual appointment marks a major shift in the company's internal structure as it moves to accelerate the delivery of its digital patient engagement platforms. These changes come at a time when the healthcare sector is under intense pressure to digitise patient communication and improve health literacy across fragmented systems. Harish Nanda assumes the role of CTO to oversee the firm's technical roadmap, while Erin Kowalow takes charge of business operations to streamline service delivery across 4 core operational pillars. The decision to bring in these executives suggests that mPulse is preparing for a period of rapid scaling, likely to meet the increasing demand for its HXI solutions from both private providers and large-scale public health institutions. The company, which specialises in using data to personalise patient interactions, needs to ensure its infrastructure remains stable while expanding its feature set. Officials confirmed that both Nanda and Kowalow would begin their duties immediately, working from the company's primary administrative offices. The move is not merely a change in personnel; it is a strategic alignment of the company's operational capacity with its long-term technical ambitions. By separating the technology and business operations functions at the executive level, mPulse aims to remove the bottlenecks that often plague fast-growing health tech firms. Analysts noted that in the current climate of high interest rates and cautious venture capital spending, such appointments signal a focus on operational efficiency and product-market fit. The company's ability to leverage patient data to drive health outcomes depends heavily on the robustness of its backend systems—an area where Nanda will be expected to make an immediate impact. Meanwhile, Kowalow's remit covers the day-to-day execution of the company's business strategy, ensuring that the firm's growth trajectory remains sustainable. The integration of these two roles is designed to create a more direct line between product development and market requirements. As the NHS and other global health services shift toward more proactive patient engagement models, the need for platforms like mPulse's has grown. The company's success will now rest on how effectively Nanda and Kowalow can harmonise their respective departments to deliver value in a complex regulatory environment. Industry observers are watching closely to see if this management shake-up results in a faster rollout of new AI-driven engagement tools.
Harish Nanda Takes the Reins of mPulse's Technical Infrastructure
As the new Chief Technology Officer, Harish Nanda faces the challenge of maintaining mPulse's position as a market leader in HXI. The technical requirements for modern patient engagement are substantial, involving secure data handling, real-time analytics, and seamless integration with existing electronic medical record systems. Nanda's primary task will be to ensure that these systems can process over 50 million patient interactions annually without compromising security or speed. The health tech industry has seen a 12% increase in demand for automated engagement tools over the past 18 months, according to industry data. This growth places a significant burden on the underlying cloud infrastructure that powers platforms like mPulse. Nanda must manage this load while simultaneously developing new features that use machine learning to predict patient needs. Experts pointed out that the transition from static messaging to dynamic, insight-driven communication is where the most significant technical hurdles exist. For Nanda, this means overseeing a team of engineers tasked with refining the predictive models that form the core of the mPulse offering. The firm's ability to provide actionable insights depends on the quality of its data processing pipeline. If the data is messy or delayed, the patient engagement strategy fails. Nanda brings experience that will be required to modernise the company's tech stack, ensuring it can handle the scale required by enterprise-level clients. Furthermore, the regulatory landscape in the UK and internationally demands strict adherence to data protection standards. Protecting patient privacy while extracting meaningful insights is a delicate balance. Nanda will need to lead the engineering team in maintaining compliance with these stringent requirements. The appointment is a clear signal that mPulse intends to double down on its technological capabilities to differentiate itself from competitors in the health engagement space. Sources confirmed that the board expects Nanda to lead the firm through its next phase of digital transformation, which includes a greater focus on interoperability with hospital information systems. This interoperability is the holy grail of digital health, allowing for a more cohesive experience for both the patient and the provider. If Nanda can achieve this, it would significantly enhance the value proposition of the mPulse platform. The technical team will now be structured to support this goal, with an emphasis on agility and rapid deployment of new software updates. With the health tech market reaching a valuation of over £200 billion globally, the stakes for technical leadership are higher than ever.
Erin Kowalow's Role in Streamlining mPulse's Business Operations
Erin Kowalow joins the executive team as Chief Business Operations Officer, a position that requires a deep understanding of both the company's internal processes and the broader market dynamics of the health sector. Her role will involve managing the operational side of the business, from resource allocation to client success programmes. In an industry where the sales cycle can be long and complex, Kowalow's ability to align operational output with commercial goals will be vital. Sources confirmed that she will focus on improving the efficiency of the company's service delivery across 10+ regions, particularly as the firm scales its operations to support a larger client base. The business operations function at mPulse is not just about internal logistics; it is about ensuring that the company's HXI solutions are delivered in a way that provides maximum value to the end user. For a healthcare provider, this means ensuring that the mPulse platform is integrated into their workflows with minimal friction. Kowalow must manage the teams responsible for implementation, training, and ongoing support. This is a critical area, as the success of any health tech solution is often determined by how easily it can be adopted by clinical staff. If the implementation process is cumbersome, even the best technology will fail to gain traction. Kowalow brings a strategic perspective to these operations, aiming to standardise the delivery process across different regions and client types. This standardisation is key to scaling the business without compromising on quality. The firm's operational strategy will also need to adapt to the changing regulatory requirements in the markets where it operates. As the company expands, Kowalow will be responsible for ensuring that all business processes remain compliant with local laws. This includes everything from data residency requirements to specific healthcare reporting standards. The pressure to deliver results is immediate, as the company looks to capitalise on the current momentum in the digital health sector. Kowalow's background in operational leadership will be tested as she looks to align the firm's internal resources with its ambitious growth targets. The goal is to build a scalable business model that can support the rapid innovation being driven by Nanda's technical team. By bridging the gap between technical development and customer-facing operations, Kowalow will play a key role in ensuring that mPulse remains the partner of choice for health organisations seeking to improve patient experiences.
The Evolution of Health Experience and Insights in the Modern Era
The appointment of Nanda and Kowalow comes at a time when the concept of Health Experience and Insights (HXI) is evolving. Traditionally, patient engagement was limited to simple appointment reminders and basic billing notifications. Today, it encompasses a much broader range of interactions that are designed to improve health outcomes and reduce costs. The industry has moved toward a model where patients are treated as active participants in their own care. This requires a platform that can provide personalised, timely, and relevant information. mPulse has been at the forefront of this shift, using data to drive engagement that actually changes health behaviours. The company's approach is rooted in the belief that better communication leads to better health, a philosophy that is gaining traction across the healthcare sector. Experts noted that the current wave of innovation in HXI is driven by the availability of more granular data. By analysing patient demographics, clinical history, and social determinants of health, providers can tailor their communication to the individual. This is where the technical and operational expertise of Nanda and Kowalow will be most critical. They will need to ensure that the platform can ingest this diverse range of data and turn it into actionable insights in real-time. The challenge is not just collecting the data, but using it in a way that is ethical and effective. As the industry matures, the focus is shifting from simply having a platform to proving the impact of that platform on health outcomes. This is why the integration of technology and business operations is so important. It is not enough to build a great tool; the company must also be able to demonstrate its value to stakeholders, including insurers, health systems, and government bodies. The market for these insights is growing by approximately 15% annually, according to recent industry reports. This growth is being driven by the need to manage chronic conditions more effectively and to reduce hospital readmission rates. As mPulse continues to refine its HXI model, it will likely face increased competition from both established health tech players and new entrants. The company's ability to stay ahead of the curve will depend on its capacity to innovate while maintaining the trust of its clients. With Nanda and Kowalow in their new roles, the company is positioning itself to lead this next chapter of health engagement.
Market Implications and the Competitive Landscape for mPulse
The news of these executive appointments has rippled through the health tech industry, with many analysts viewing it as a sign of confidence in mPulse's future. The market for patient engagement software is becoming increasingly crowded, with over 20+ competitors vying for the same client base. For mPulse, the ability to differentiate its offering through superior technology and efficient operations is essential. The company has already established a strong presence in the HXI space, but it must continue to evolve to maintain its lead. Competitors are constantly introducing new features and lowering prices, which puts pressure on mPulse to demonstrate the unique value of its platform. The appointment of Nanda and Kowalow suggests that the company is taking these competitive pressures seriously. By strengthening its leadership team, mPulse is sending a message that it is committed to excellence in both product and execution. This is a crucial signal to investors and existing clients who are looking for stability and growth. The company's strategy of focusing on deep, data-driven insights provides a clear point of differentiation. While other firms may focus on mass communication, mPulse's emphasis on personalised engagement is a more sustainable long-term strategy. The challenge, however, is to scale this personalisation without increasing costs to a point where it becomes prohibitive for smaller health systems. This is where Kowalow's focus on operational efficiency will be tested. If she can find ways to streamline the delivery of these personalised programmes, it will significantly enhance the company's competitive advantage. Meanwhile, Nanda's role in developing the underlying tech will ensure that the platform remains at the cutting edge of what is possible in digital health. The combination of these two leaders is designed to create a more integrated and responsive organisation. As the healthcare sector continues to digitise, the demand for platforms that can bridge the gap between patient and provider will only grow. mPulse is well-positioned to meet this demand, but it must execute its strategy with precision. The coming months will be a test of how well this new leadership team can work together to achieve these goals. Observers are particularly interested in seeing how the company's product roadmap develops under Nanda's guidance. Will we see a move toward more AI-driven automation? Will the platform become more integrated with the wider healthcare ecosystem? These are the questions that will define the success of the new leadership team.
What Lies Ahead for the mPulse Roadmap in 2027
Looking toward 2027, the focus for mPulse will be on executing the 3-year strategic roadmap set forth by its new leadership team. The company has a clear path forward, but it will require disciplined execution to realise its potential. The integration of Nanda's technical expertise and Kowalow's operational rigour will be the defining factor in the company's success. The roadmap for the coming year is expected to include a significant expansion of the company's data analytics capabilities, allowing for even more precise patient targeting. This will be supported by a new suite of 5 analytical tools designed to help providers track the impact of their engagement programmes on patient health outcomes. These tools will be critical for demonstrating the ROI of the mPulse platform, which is a key requirement for any health system today. Furthermore, the company is expected to continue its expansion into new international markets, where the demand for digital health solutions is rapidly increasing. The ability to adapt the platform to different regulatory and cultural contexts will be a key challenge for the new leadership team. Kowalow will play a central role in managing this expansion, ensuring that the company's operations are robust enough to support a global footprint. Meanwhile, Nanda will be responsible for ensuring that the technical infrastructure can handle the increased load and complexity of these new markets. The company's commitment to its core mission—improving health through better communication—remains unchanged. However, the way it delivers on this mission is set to become more sophisticated and data-driven. As mPulse enters this new phase, the industry will be watching to see how these executive changes translate into tangible results. With the right leadership in place, the company is well-placed to continue its growth and solidify its position as the leader in Health Experience and Insights. The path ahead is challenging, but the potential rewards for the company, its clients, and the patients they serve are significant. As the healthcare sector continues its transformation, mPulse is poised to play a central role in shaping the future of patient engagement.